CIK 0001582313
- Large accelerated filer
Xenon Pharmaceuticals Inc.
Sign in to watch- Ticker
- XENE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- British Columbia, Canada
- Entity type
- Operating
- EIN
- 980661854
- Phone
- +1 604-484-3300
- Business address
- 200 - 3650 GILMORE WAY, BURNABY, British Columbia, Canada
- Open-market buys, last 90 days
- $1,681,140
- in 2 filings
- Open-market sales, last 90 days
- $425,829
- in 1 filing, $426K under 10b5-1 plans
Net +$1,255,311. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-10-15 | Kelly Thomas Patrick Chief Financial Officer | Option exercise | +7,500 | 22,500 | ||
| 2026-10-15 | Kelly Thomas Patrick Chief Financial Officer | Option exercise · Restricted Share Units | −7,500 | 22,500 | ||
| 2026-09-30 | Kelly Thomas Patrick Chief Financial Officer | Purchase | +15,000 | $37.32 | $560K | 15,000 |
| 2025-10-15 | Kelly Thomas Patrick Chief Financial Officer | Grant or award · Share Option (Right to Buy) | +225,000 | 225,000 | ||
| 2025-10-15 | Kelly Thomas Patrick Chief Financial Officer | Grant or award · Restricted Share Units | +30,000 | 30,000 |
Page 1 of 1 · 5 trades